Tvardi Share Price
NASDAQ: TVRD | Micro Cap | HealthcareTvardi Stock Performance
Tvardi Share Price Today
As of 21 November 2026, Tvardi Therapeutics, Inc.'s share price is $1.00. The stock opened at $0.92, compared to its previous close of $1.01. During today's trading session, Tvardi Therapeutics, Inc.'s share price traded between $0.92 and $1.00, with an average price of $0.96. Over the past 52 weeks, the stock has recorded a high of $5.66 and a low of $0.79. In terms of performance, Tvardi Therapeutics, Inc.'s share price has declined by 70.57% over the last six months and is down 75.81% on a year-on-year basis.
Tvardi Share Price Chart
Tvardi Quarterly Profit & Loss
All figures in USD
Tvardi Annual Profit & Loss
All figures in USD
Tvardi Balance Sheet
All figures in USD Million
Tvardi Cash Flow
All figures in USD Million
About Tvardi
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.
Tvardi Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.83 | $1.00 | +23.24% |
Oct 2026 | $1.22 | $0.81 | -34.76% |
Sep 2026 | $1.81 | $1.24 | -32.24% |
Aug 2026 | $2.06 | $1.83 | -13.27% |
Jul 2026 | $1.86 | $2.11 | +9.61% |
Jun 2026 | $3.33 | $1.93 | -43.22% |
May 2026 | $3.13 | $3.39 | +8.31% |
Apr 2026 | $3.11 | $3.13 | -1.57% |
Mar 2026 | $4.11 | $3.18 | -20.10% |
Feb 2026 | $3.93 | $3.98 | +0.76% |
Jan 2026 | $4.26 | $3.95 | -8.35% |
Dec 2025 | $4.08 | $4.31 | +4.48% |